Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

The association between self-reported lack of sleep, low vitality and impaired glucose tolerance: a Swedish cross-sectional study

Authors: Susanne Andersson, Inger Ekman, Febe Friberg, Erik Bøg-Hansen, Ulf Lindblad

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

The increased incidence of impaired glucose tolerance (IGT), are serious public health issues, and several studies link sleeping disorders with increased risk of developing type 2 diabetes, impaired glucose tolerance and insulin resistance (IR). This study explore how self-reported lack of sleep and low vitality, are associated with IGT in a representative Swedish population.

Methods

A cross-sectional survey conducted in two municipalities in South-western Sweden. Participants aged 30–75 were randomly selected from the population in strata by sex and age. Altogether, 2,816 participants were surveyed with a participation rates at 76%. Participants with normal glucose tolerance (n=2,314), and those with IGT (n=213) were retained for analyses. The participants answered a questionnaire before the oral glucose tolerance test (OGTT). Associations for questions concerning sleeping disorders, vitality and IGT were analysed using logistic regression and were expressed as odds ratios (OR) with 95% CI.

Results

In men a statistically significant age-adjusted association was found between self-reported lack of sleep and IGT: OR 2.4 (95% CI: 1.1-5.4). It did not weaken after further adjustment for body mass index (BMI), smoking, education, and leisure time physical activity 2.3 (1.0-5.5, p=0.044). No such associations were found in females. Corresponding age-adjusted associations between low vitality and IGT in both men 2.8 (1.3-5.8), and women 2.0 (1.2-3.4) were successively lost with increasing adjustment.

Conclusions

Insufficient sleep seems independently associated with IGT in men, while low vitality was not independently associated with IGT neither in men nor women, when multiple confounders are considered. IGT should be considered in patients presenting these symptoms, and underlying mechanisms further explored.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2009, 87: 4-14.CrossRefPubMed Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2009, 87: 4-14.CrossRefPubMed
2.
go back to reference Rao SS, Disraeli P, McGregor T: Impaired glucose tolerance and impaired fasting glucose. Am Fam Physician. 1961, 2004: 69- Rao SS, Disraeli P, McGregor T: Impaired glucose tolerance and impaired fasting glucose. Am Fam Physician. 1961, 2004: 69-
3.
go back to reference Barzilay JI, Spiekerman CF, Wahl PW, Kuller LH, Cushman M, Furberg CD, Dobs A, Polak JF, Savage PJ: Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet. 1999, 354: 622-625. 10.1016/S0140-6736(98)12030-5.CrossRefPubMed Barzilay JI, Spiekerman CF, Wahl PW, Kuller LH, Cushman M, Furberg CD, Dobs A, Polak JF, Savage PJ: Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet. 1999, 354: 622-625. 10.1016/S0140-6736(98)12030-5.CrossRefPubMed
4.
go back to reference Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992, 340: 925-929. 10.1016/0140-6736(92)92814-V.CrossRefPubMed Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992, 340: 925-929. 10.1016/0140-6736(92)92814-V.CrossRefPubMed
5.
go back to reference Abdul-Ghani MA, DeFronzo RA: Pathophysiology of prediabetes. Curr Diab Rep. 2009, 9: 193-199. 10.1007/s11892-009-0032-7.CrossRefPubMed Abdul-Ghani MA, DeFronzo RA: Pathophysiology of prediabetes. Curr Diab Rep. 2009, 9: 193-199. 10.1007/s11892-009-0032-7.CrossRefPubMed
6.
go back to reference Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002, 19: 708-723.CrossRefPubMed Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002, 19: 708-723.CrossRefPubMed
7.
go back to reference Pack AI, Pien GW: Update on sleep and its disorders. Annu Rev Med. 2011, 62: 447-460. 10.1146/annurev-med-050409-104056.CrossRefPubMed Pack AI, Pien GW: Update on sleep and its disorders. Annu Rev Med. 2011, 62: 447-460. 10.1146/annurev-med-050409-104056.CrossRefPubMed
8.
go back to reference Seicean S, Kirchner HL, Gottlieb DJ, Punjabi NM, Resnick H, Sanders M, Budhiraja R, Singer M, Redline S: Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study. Diabetes Care. 2008, 31: 1001-1006. 10.2337/dc07-2003.CrossRefPubMed Seicean S, Kirchner HL, Gottlieb DJ, Punjabi NM, Resnick H, Sanders M, Budhiraja R, Singer M, Redline S: Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study. Diabetes Care. 2008, 31: 1001-1006. 10.2337/dc07-2003.CrossRefPubMed
9.
go back to reference Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002, 165: 677-682. 10.1164/ajrccm.165.5.2104087.CrossRefPubMed Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002, 165: 677-682. 10.1164/ajrccm.165.5.2104087.CrossRefPubMed
10.
go back to reference Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, Nieto FJ: Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005, 165: 863-868. 10.1001/archinte.165.8.863.CrossRefPubMed Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, Nieto FJ: Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005, 165: 863-868. 10.1001/archinte.165.8.863.CrossRefPubMed
11.
go back to reference Punjabi NM: Do sleep disorders and associated treatments impact glucose metabolism?. Drugs. 2009, 69 (Suppl 2): 13-27.CrossRefPubMed Punjabi NM: Do sleep disorders and associated treatments impact glucose metabolism?. Drugs. 2009, 69 (Suppl 2): 13-27.CrossRefPubMed
12.
go back to reference Barone MT, Menna-Barreto L: Diabetes and sleep: a complex cause-and-effect relationship. Diabetes Res Clin Pract. 2010, 91: 129-137.CrossRef Barone MT, Menna-Barreto L: Diabetes and sleep: a complex cause-and-effect relationship. Diabetes Res Clin Pract. 2010, 91: 129-137.CrossRef
13.
go back to reference Andersson S, Ekman I, Lindblad U, Friberg F: Perceived Symptoms in People Living with Impaired Glucose Tolerance. Nurs Res Pract. 2011, 10.1155/2011/937038. Andersson S, Ekman I, Lindblad U, Friberg F: Perceived Symptoms in People Living with Impaired Glucose Tolerance. Nurs Res Pract. 2011, 10.1155/2011/937038.
14.
go back to reference Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ: Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 2008, 81: 2-12. 10.1016/j.diabres.2008.04.025.CrossRefPubMed Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ: Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 2008, 81: 2-12. 10.1016/j.diabres.2008.04.025.CrossRefPubMed
15.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 7: 393-403. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 7: 393-403.
16.
go back to reference Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 3: 1343-1350.CrossRef Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 3: 1343-1350.CrossRef
17.
go back to reference Larsson CA, Gullberg B, Råstam L, Lindblad U: Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study. BMC Endocrin Disord. 2009, 9: 16-10.1186/1472-6823-9-16.CrossRef Larsson CA, Gullberg B, Råstam L, Lindblad U: Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study. BMC Endocrin Disord. 2009, 9: 16-10.1186/1472-6823-9-16.CrossRef
18.
go back to reference Göransson M, Hanson BS: How much can data on days with heavy drinking decrease the underestimation of true alcohol consumption?. J Stud Alcohol. 1994, 55: 695-700.CrossRefPubMed Göransson M, Hanson BS: How much can data on days with heavy drinking decrease the underestimation of true alcohol consumption?. J Stud Alcohol. 1994, 55: 695-700.CrossRefPubMed
19.
go back to reference Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed
20.
go back to reference Chaput JP, Despres JP, Bouchard C, Astrup A, Tremblay A: Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med. 2009, 10: 919-924. 10.1016/j.sleep.2008.09.016.CrossRefPubMed Chaput JP, Despres JP, Bouchard C, Astrup A, Tremblay A: Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med. 2009, 10: 919-924. 10.1016/j.sleep.2008.09.016.CrossRefPubMed
21.
go back to reference Bonnet MH, Arand DL: Clinical effects of sleep fragmentation versus sleep deprivation. Sleep Med Rev. 2003, 7: 297-310. 10.1053/smrv.2001.0245.CrossRefPubMed Bonnet MH, Arand DL: Clinical effects of sleep fragmentation versus sleep deprivation. Sleep Med Rev. 2003, 7: 297-310. 10.1053/smrv.2001.0245.CrossRefPubMed
22.
go back to reference Schubert CR, Cruickshanks KJ, Dalton DS, Klein BE, Klein R, Nondahl DM: Prevalence of sleep problems and quality of life in an older population. Sleep. 2002, 25: 889-893.PubMed Schubert CR, Cruickshanks KJ, Dalton DS, Klein BE, Klein R, Nondahl DM: Prevalence of sleep problems and quality of life in an older population. Sleep. 2002, 25: 889-893.PubMed
23.
go back to reference Bonnet MH, Arand DL: We are chronically sleep deprived. Sleep. 1995, 18: 908-911.PubMed Bonnet MH, Arand DL: We are chronically sleep deprived. Sleep. 1995, 18: 908-911.PubMed
24.
go back to reference Pagel JF: Excessive daytime sleepiness. Am Fam Physician. 2009, 79: 391-396.PubMed Pagel JF: Excessive daytime sleepiness. Am Fam Physician. 2009, 79: 391-396.PubMed
25.
go back to reference Young T, Peppard PE, Taheri S: Excess weight and sleep-disordered breathing. J Appl Physiol. 2005, 99: 1592-1599. 10.1152/japplphysiol.00587.2005.CrossRefPubMed Young T, Peppard PE, Taheri S: Excess weight and sleep-disordered breathing. J Appl Physiol. 2005, 99: 1592-1599. 10.1152/japplphysiol.00587.2005.CrossRefPubMed
26.
go back to reference Tuomilehto H, Peltonen M, Partinen M, Seppa J, Saaristo T, Korpi-Hyovalti E, Oksa H, Saltevo J, Puolijoki H, Vanhala M, Tuomilehto J: Sleep-disordered breathing is related to an increased risk for type 2 diabetes in middle-aged men, but not in women–the FIN-D2D survey. Diabetes Obes Metab. 2008, 10: 468-475. 10.1111/j.1463-1326.2007.00729.x.CrossRefPubMed Tuomilehto H, Peltonen M, Partinen M, Seppa J, Saaristo T, Korpi-Hyovalti E, Oksa H, Saltevo J, Puolijoki H, Vanhala M, Tuomilehto J: Sleep-disordered breathing is related to an increased risk for type 2 diabetes in middle-aged men, but not in women–the FIN-D2D survey. Diabetes Obes Metab. 2008, 10: 468-475. 10.1111/j.1463-1326.2007.00729.x.CrossRefPubMed
27.
go back to reference Björkelund C, Bondyr-Carlsson D, Lapidus L, Lissner L, Månsson J, Skoog I, Bengtsson C: Sleep disturbances in midlife unrelated to 32-year diabetes incidence: the prospective population study of women in Gothenburg. Diabetes Care. 2005, 28: 2739-2744. 10.2337/diacare.28.11.2739.CrossRefPubMed Björkelund C, Bondyr-Carlsson D, Lapidus L, Lissner L, Månsson J, Skoog I, Bengtsson C: Sleep disturbances in midlife unrelated to 32-year diabetes incidence: the prospective population study of women in Gothenburg. Diabetes Care. 2005, 28: 2739-2744. 10.2337/diacare.28.11.2739.CrossRefPubMed
28.
29.
go back to reference Hegadoren KM, O'Donnell T, Lanius R, Coupland NJ, Lacaze-Masmonteil N: The role of beta-endorphin in the pathophysiology of major depression. Neuropeptides. 2009, 43: 341-353. 10.1016/j.npep.2009.06.004.CrossRefPubMed Hegadoren KM, O'Donnell T, Lanius R, Coupland NJ, Lacaze-Masmonteil N: The role of beta-endorphin in the pathophysiology of major depression. Neuropeptides. 2009, 43: 341-353. 10.1016/j.npep.2009.06.004.CrossRefPubMed
30.
go back to reference Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S, Östenson CG: Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med. 2008, 25: 834-842. 10.1111/j.1464-5491.2008.02463.x.CrossRefPubMed Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S, Östenson CG: Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med. 2008, 25: 834-842. 10.1111/j.1464-5491.2008.02463.x.CrossRefPubMed
31.
go back to reference Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJ, Manning AK, Jackson AU, Aulchenko Y, Potter SC, Erdos MR, Sanna S, Hottenga JJ, Wheeler E, Kaakinen M, Lyssenko V, Chen WM, Ahmadi K, Beckmann JS, Bergman RN, Bochud M, Bonnycastle LL, Buchanan TA, Cao A, Cervino A, Coin L, Collins FS, Crisponi L, de Geus EJ, et al: Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009, 41: 77-81. 10.1038/ng.290.CrossRefPubMed Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJ, Manning AK, Jackson AU, Aulchenko Y, Potter SC, Erdos MR, Sanna S, Hottenga JJ, Wheeler E, Kaakinen M, Lyssenko V, Chen WM, Ahmadi K, Beckmann JS, Bergman RN, Bochud M, Bonnycastle LL, Buchanan TA, Cao A, Cervino A, Coin L, Collins FS, Crisponi L, de Geus EJ, et al: Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009, 41: 77-81. 10.1038/ng.290.CrossRefPubMed
32.
go back to reference Bartnik M, Ryden L, Malmberg K, Öhrvik J, Pyörälä K, Standl E, Ferrari R, Simoons M, Soler-Soler J: Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart. 2007, 93: 72-77. 10.1136/hrt.2005.086975.CrossRefPubMed Bartnik M, Ryden L, Malmberg K, Öhrvik J, Pyörälä K, Standl E, Ferrari R, Simoons M, Soler-Soler J: Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart. 2007, 93: 72-77. 10.1136/hrt.2005.086975.CrossRefPubMed
33.
go back to reference Emaus A, Degerstrøm J, Wilsgaard T, Hansen BH, Dieli-Conwright CM, Furberg AS, Pettersen SA, Andersen LB, Eggen AE, Bernstein L, Thune I: Does a variation in self-reported physical activity reflect variation in objectively measured physical activity, resting heart rate, and physical fitness? Results from the Tromsø study. Scand J Public Health. 2010, 38: 105-118. 10.1177/1403494810378919.CrossRefPubMed Emaus A, Degerstrøm J, Wilsgaard T, Hansen BH, Dieli-Conwright CM, Furberg AS, Pettersen SA, Andersen LB, Eggen AE, Bernstein L, Thune I: Does a variation in self-reported physical activity reflect variation in objectively measured physical activity, resting heart rate, and physical fitness? Results from the Tromsø study. Scand J Public Health. 2010, 38: 105-118. 10.1177/1403494810378919.CrossRefPubMed
34.
go back to reference Broman JE, Smedje H, Mallon L, Hetta J: The Minimal Insomnia Symptom Scale (MISS): a brief measure of sleeping difficulties. Upsala J Med Sci. 2008, 113: 131-142. 10.3109/2000-1967-221.CrossRefPubMed Broman JE, Smedje H, Mallon L, Hetta J: The Minimal Insomnia Symptom Scale (MISS): a brief measure of sleeping difficulties. Upsala J Med Sci. 2008, 113: 131-142. 10.3109/2000-1967-221.CrossRefPubMed
35.
go back to reference Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, Westlake L: Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992, 305: 160-164. 10.1136/bmj.305.6846.160.CrossRefPubMedPubMedCentral Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, Westlake L: Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992, 305: 160-164. 10.1136/bmj.305.6846.160.CrossRefPubMedPubMedCentral
36.
go back to reference Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Res. 1989, 28: 193-213. 10.1016/0165-1781(89)90047-4.CrossRefPubMed Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Res. 1989, 28: 193-213. 10.1016/0165-1781(89)90047-4.CrossRefPubMed
37.
go back to reference Yaggi HK, Araujo AB, McKinlay JB: Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006, 29: 657-661. 10.2337/diacare.29.03.06.dc05-0879.CrossRefPubMed Yaggi HK, Araujo AB, McKinlay JB: Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006, 29: 657-661. 10.2337/diacare.29.03.06.dc05-0879.CrossRefPubMed
Metadata
Title
The association between self-reported lack of sleep, low vitality and impaired glucose tolerance: a Swedish cross-sectional study
Authors
Susanne Andersson
Inger Ekman
Febe Friberg
Erik Bøg-Hansen
Ulf Lindblad
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-700

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue